Article
Metabolic syndrome and risk of colorectal cancer: A Mendelian randomization study
19 Dec 2023
Abstract excerpt
Background: Observational studies have previously demonstrated a significant relationship among both metabolic syndrome (Mets) and colorectal cancer (CRC). Whether there is a causal link remains controversial. Objective: To clarify whether Mets and their components have a causal effect on colorectal cancer, we have carried out a bidirectional Mendelian randomization analysis (MR). Methods: This study started from...
Topics
Join the communities discussing this publication.